Reinsurance Gr: Q1 Earnings Insights

Reinsurance Gr (NYSE:RGA) reported its Q1 earnings results on Thursday, May 4, 2023 at 04:15 PM. Here’s what…

Reinsurance Gr (NYSE:RGA) reported its Q1 earnings results on Thursday, May 4, 2023 at 04:15 PM.

Here’s what investors need to know about the announcement.

Earnings

Reinsurance Gr beat estimated earnings by 52.66%, reporting an EPS of $5.16 versus an estimate of $3.38.

Revenue was up $321.00 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.74 which was followed by a 3.07% drop in the share price the next day.

Here’s a look at Reinsurance Gr’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 3.73 3.24 2.78 -0.55
EPS Actual 2.99 5.20 5.78 0.47
Revenue Estimate 4.27B 4.01B 4.01B 3.89B
Revenue Actual 4.38B 4.07B 3.89B 3.93B

To track all earnings releases for Reinsurance Gr visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY

Cannabinoids-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) reported on Tuesday year-end 2023 results and audited financial statements. The Canadian company reported CA$16.8 million ($12.3 million) in total revenue, up by 314% year-over-year. Avicanna mostly attributed a surge in revenue to the acquisition of Medical Cannabis by Shoppers from Shoppers Drug Mart and the launch of MyMedi.ca. "2023 was a tremendous year for Avicanna where we solidified our leadership position in the Canadian medical cannabis sector through our proprietary products and the launch of MyMedi.ca," he said. "We have successfully demonstrated the scalability of our revenues and made significant improvements in our fundamentals while advancing all our business pillars."

AVCNF